Wealthcare Advisory Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+3,852
New +$188K ﹤0.01% 1026
2021
Q2
Sell
-100
Closed -$2K 949
2021
Q1
$2K Buy
+100
New +$2.26K ﹤0.01% 1864
2020
Q2
Sell
-100
Closed -$2K 646
2020
Q1
$2K Hold
100
﹤0.01% 1284
2019
Q4
$2K Hold
100
﹤0.01% 1255
2019
Q3
$2K Hold
100
﹤0.01% 1211
2019
Q2
$2K Hold
100
﹤0.01% 1182
2019
Q1
$2K Hold
100
﹤0.01% 1091
2018
Q4
$2K Hold
100
﹤0.01% 1075
2018
Q3
$2K Hold
100
﹤0.01% 1117
2018
Q2
$2K Sell
100
-300
-75% -$6.2K ﹤0.01% 1116
2018
Q1
$9K Hold
400
﹤0.01% 744
2017
Q4
$12K Hold
400
﹤0.01% 628
2017
Q3
$10K Buy
+400
New +$10.6K ﹤0.01% 543

Other funds holding EXEL

Wealthcare Advisory Partners's EXEL Position: Q2 2026 in Review

Wealthcare Advisory Partners opened a new position in Exelixis (EXEL) in Q2 2026: 3,852 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1026 among its holdings. This is a return to the name: Wealthcare Advisory Partners previously reported a position in EXEL as recently as Q1 2021.

Wealthcare Advisory Partners first reported a position in EXEL in Q3 2017 and has held it in 13 quarters since. 83 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Wealthcare Advisory Partners held 3,852 shares of Exelixis worth $210K as of Q2 2026.
  • Exelixis was a new Wealthcare Advisory Partners position in Q2 2026.
  • Exelixis made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #1026 holding.
  • Wealthcare Advisory Partners first reported a position in Exelixis in Q3 2017 and has held it in 13 quarters since.
  • 83 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.